APA

Mackern-Oberti J. P., Riquelme S. A., Llanos C., Schmidt C. B., Simon T., Anegon I., Jara E., Riedel C. A., Bueno S. M. & Kalergis A. M. (20150511). Heme oxygenase-1 as a target for the design of gene and pharmaceutical therapies for autoimmune diseases. : Current gene therapy.

Chicago

Mackern-Oberti Juan P, Riquelme Sebastian A, Llanos Carolina, Schmidt Camila B, Simon Thomas, Anegon Ignacio, Jara Evelyn, Riedel Claudia A, Bueno Susan M and Kalergis Alexis M. 20150511. Heme oxygenase-1 as a target for the design of gene and pharmaceutical therapies for autoimmune diseases. : Current gene therapy.

Harvard

Mackern-Oberti J. P., Riquelme S. A., Llanos C., Schmidt C. B., Simon T., Anegon I., Jara E., Riedel C. A., Bueno S. M. and Kalergis A. M. (20150511). Heme oxygenase-1 as a target for the design of gene and pharmaceutical therapies for autoimmune diseases. : Current gene therapy.

MLA

Mackern-Oberti Juan P, Riquelme Sebastian A, Llanos Carolina, Schmidt Camila B, Simon Thomas, Anegon Ignacio, Jara Evelyn, Riedel Claudia A, Bueno Susan M and Kalergis Alexis M. Heme oxygenase-1 as a target for the design of gene and pharmaceutical therapies for autoimmune diseases. : Current gene therapy. 20150511.